BioCryst’s oral therapy reaches pivotal studies in paroxysmal nocturnal hemoglobinuria
March 23 2021 - 9:31AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From Sep 2023 to Sep 2024